DE69833317D1 - Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn - Google Patents
Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohnInfo
- Publication number
- DE69833317D1 DE69833317D1 DE69833317T DE69833317T DE69833317D1 DE 69833317 D1 DE69833317 D1 DE 69833317D1 DE 69833317 T DE69833317 T DE 69833317T DE 69833317 T DE69833317 T DE 69833317T DE 69833317 D1 DE69833317 D1 DE 69833317D1
- Authority
- DE
- Germany
- Prior art keywords
- crohn
- colitis
- morbon
- conagenine
- ultra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010009887 colitis Diseases 0.000 title abstract 2
- XXCXSSMNJUZBQI-UHFFFAOYSA-N 2-[(3,4-dihydroxy-2-methylpentanoyl)amino]-3-hydroxy-2-methylpropanoic acid Chemical compound CC(O)C(O)C(C)C(=O)NC(C)(CO)C(O)=O XXCXSSMNJUZBQI-UHFFFAOYSA-N 0.000 title 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- GLESHRYLRAOJPS-DHCFDGJBSA-N conagenin Chemical compound C[C@@H](O)[C@H](C)[C@@H](O)C(=O)N[C@@](C)(CO)C(O)=O GLESHRYLRAOJPS-DHCFDGJBSA-N 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Soy Sauces And Products Related Thereto (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9068897 | 1997-04-09 | ||
| PCT/JP1998/001614 WO1998044916A1 (fr) | 1997-04-09 | 1998-04-08 | Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE69833317D1 true DE69833317D1 (de) | 2006-04-13 |
Family
ID=14005483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69833317T Expired - Lifetime DE69833317D1 (de) | 1997-04-09 | 1998-04-08 | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6160017A (de) |
| EP (1) | EP0987022B1 (de) |
| JP (1) | JP4019158B2 (de) |
| KR (1) | KR100356899B1 (de) |
| AT (1) | ATE316373T1 (de) |
| AU (1) | AU727289B2 (de) |
| CA (1) | CA2288966C (de) |
| DE (1) | DE69833317D1 (de) |
| HU (1) | HUP0000716A3 (de) |
| NO (1) | NO994930L (de) |
| WO (1) | WO1998044916A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090253794A1 (en) * | 2005-07-22 | 2009-10-08 | Jun Tomono | Fibroblast Activator, Collagen Production Promoter, Collagen Contraction Promoter, Hyaluronic Acid Production Promoter, ATP Production Promoter, Melanin Formation Inhibitor, and Agent for External Application to the Skin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4078397B2 (ja) * | 1994-10-14 | 2008-04-23 | 財団法人微生物化学研究会 | 下痢の予防及び治療剤 |
-
1998
- 1998-04-08 WO PCT/JP1998/001614 patent/WO1998044916A1/ja active IP Right Grant
- 1998-04-08 US US09/402,534 patent/US6160017A/en not_active Expired - Fee Related
- 1998-04-08 AU AU67468/98A patent/AU727289B2/en not_active Ceased
- 1998-04-08 HU HU0000716A patent/HUP0000716A3/hu unknown
- 1998-04-08 EP EP98912719A patent/EP0987022B1/de not_active Expired - Lifetime
- 1998-04-08 KR KR1019997009214A patent/KR100356899B1/ko not_active IP Right Cessation
- 1998-04-08 AT AT98912719T patent/ATE316373T1/de not_active IP Right Cessation
- 1998-04-08 DE DE69833317T patent/DE69833317D1/de not_active Expired - Lifetime
- 1998-04-08 JP JP54260198A patent/JP4019158B2/ja not_active Expired - Fee Related
- 1998-04-08 CA CA002288966A patent/CA2288966C/en not_active Expired - Fee Related
-
1999
- 1999-10-08 NO NO994930A patent/NO994930L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0000716A3 (en) | 2000-10-30 |
| AU6746898A (en) | 1998-10-30 |
| CA2288966A1 (en) | 1998-10-15 |
| NO994930L (no) | 1999-12-08 |
| NO994930D0 (no) | 1999-10-08 |
| WO1998044916A1 (fr) | 1998-10-15 |
| HUP0000716A2 (hu) | 2000-09-28 |
| AU727289B2 (en) | 2000-12-07 |
| KR100356899B1 (ko) | 2002-10-31 |
| EP0987022A4 (de) | 2004-03-31 |
| ATE316373T1 (de) | 2006-02-15 |
| EP0987022B1 (de) | 2006-01-25 |
| EP0987022A1 (de) | 2000-03-22 |
| US6160017A (en) | 2000-12-12 |
| JP4019158B2 (ja) | 2007-12-12 |
| KR20010006136A (ko) | 2001-01-26 |
| CA2288966C (en) | 2004-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0509317A3 (en) | Use of droloxifene in the treatment of bone diseases | |
| DE3382458D1 (de) | Haarwuchsmittel. | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| DK1137762T3 (da) | Behandling af Pompes sygdom | |
| HRP920667A2 (en) | Application of fultripine active substance for preventing muscle deformation | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| FI951856A0 (fi) | Farmaseuttinen koostumus osteoporoosin hoitamiseksi | |
| ATE386520T1 (de) | Kombination von riluzol und levodopa zur behandlung von morbus parkinson | |
| DE69327328T2 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
| DE69833317D1 (de) | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn | |
| ES2190499T3 (es) | Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer. | |
| DE69307702D1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| DE69304266T2 (de) | Zusammensetzung enthaltend Dibucaine-Hydrochlorid, ein Salicylat, Calciumbromid und ein antiphlogistisches steroid zur Schmerzbekämpfung | |
| ATE223212T1 (de) | Conagenine zur prävention und behandlung von diarrhöe | |
| EP0182569A3 (en) | Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages | |
| UA30143C2 (uk) | Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань | |
| TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
| MY110416A (en) | Composition for the treatment of schizophrenia. | |
| LV5179A3 (lv) | Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai | |
| IT8919215A0 (it) | Dispositivo per la cura chirurgica dell'ametropia. | |
| KR890000089A (ko) | 신장 질환 치료제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |